FMP
Nemaura Medical Inc.
NMRD
NASDAQ
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
0.0002 USD
0 (0%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Dr. Dewan Fazlul Hoque Chowdhury Ph.D.
sector
Healthcare
industry
Medical - Devices
website
https://nemauramedical.comexchange
NASDAQ
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
CIK
0001602078
ISIN
US6404422080
CUSIP
640442208
Address
57 West 57th Street
Phone
646 416 7912
Country
US
Employee
36
IPO Date
Feb 5, 2018
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
NMRD Financial Summary
CIK
0001602078
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
640442208
ISIN
US6404422080
Country
US
Price
0
Beta
0.08
Volume Avg.
5.74k
Market Cap
8.07k
Shares
-
52-Week
1.0E-4-0.2537
DCF
3.4
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
0
P/B
-
Website
https://nemauramedical.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest NMRD News
It looks like there's no news available.
